We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PFIZER AGREES TO DELAY LAUNCH OF COX-2 POLYP DRUG
PFIZER AGREES TO DELAY LAUNCH OF COX-2 POLYP DRUG
January 21, 2005
Amid the growing uncertainty about the safety of Cox-2 inhibitors, Pfizer has agreed to delay the European launch of Onsenal, a Cox-2 drug approved in the EU for the treatment of intestinal polyps.